WEBINAR: What's New in Food Allergy and What Does It Mean for Us?

March 28, 2024, 1:00 p.m. ET 

This is an exciting time with a new therapy that has been FDA approved, new devices that are getting closer to FDA approval, new approaches to treatment in the pipeline and new ways to think about anaphylaxis management.  The timing could not be better as the American Academy of Allergy, Asthma & Immunology (AAAAI) recently held their annual meeting in Washington DC. Join us for this hour-long webinar, during which FARE's Senior Director of Education and Support Programs, Dr. Kelly Cleary, will talk to Dr. Michael Pistiner, an allergist/immunologist, and Director of Food Allergy Advocacy, Education and Prevention for Mass General for Children, Food Allergy Center. They will discuss the allergist's take on these new developments and explore how this may impact our food allergy community. You can learn about what's new, what’s coming and the questions you should ask your allergist!

This event is supported by 

About the Speakers

Michael Pistiner, MD

Michael Pistiner, MD, MMSc is Director of Food Allergy Advocacy, Education and Prevention for Mass General for Children, Food Allergy Center. He has a special interest in food allergy and anaphylaxis education and advocacy, infant food allergy management,  healthcare provider education, facilitating collaborations between the medical home and school health, and maintaining quality of life in children (and their families) with food allergies.  Dr. Pistiner is a fellow in the American Academy of Pediatrics (AAP), where he is a member of the Section on Allergy and Immunology, Council on School Health and the Massachusetts Chapter of the AAP. He is also a member of the American Academy of Allergy Asthma & Immunology and the American College of Allergy, Asthma and Immunology.

Kelly Cleary, MD

Dr. Kelly Cleary is the Senior Director of Education and Support Programs for FARE. She oversees FARE’s national education efforts and maintains a variety of programs, resources, and relationships for the food allergic, their families, and caregivers. Previously, Kelly was the Medical Director of Psychopharmacology for PM Behavioral Health, where she was responsible for the oversight of medication management and operations for the behavioral health service. Kelly also co-founded UrgiKids, a pediatric urgent care in Naperville, Illinois which was subsequently acquired by PM Pediatrics. A graduate of Albert Einstein College of Medicine, Kelly completed her Pediatrics residency at New York Presbyterian Cornell, and finished her Pediatric Emergency Medicine fellowship at NYU-Bellevue. She is currently pursuing a Master’s in Public Health degree at Johns Hopkins Bloomberg School of Public Health.